Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Sienkiewicz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancers|May 28, 2022
Bispecific BCMA-CD3 Antibodies Block Multiple Myeloma Tumor GrowthLijun Wu, Yanwei Huang, John Sienkiewicz, et al.
International Journal of Molecular Sciences|September 9, 2023
CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In VivoVita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
Biomedicines|October 23, 2021
Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple MyelomaVita Golubovskaya, Hua Zhou, Feng Li, et al.
Cancers|June 22, 2023
mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor GrowthVita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
Cancers|March 3, 2021
Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T Cells Specifically Target LymphomaVita Golubovskaya, Hua Zhou, Feng Li, et al.
Vaccines|July 27, 2024
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor GrowthLiang Hu, Shiming Zhang, John Sienkiewicz, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancers|May 28, 2022
Bispecific BCMA-CD3 Antibodies Block Multiple Myeloma Tumor GrowthLijun Wu, Yanwei Huang, John Sienkiewicz, et al.
International Journal of Molecular Sciences|September 9, 2023
CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In VivoVita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
Biomedicines|October 23, 2021
Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple MyelomaVita Golubovskaya, Hua Zhou, Feng Li, et al.
Cancers|June 22, 2023
mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor GrowthVita Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
Cancers|March 3, 2021
Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T Cells Specifically Target LymphomaVita Golubovskaya, Hua Zhou, Feng Li, et al.
Vaccines|July 27, 2024
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor GrowthLiang Hu, Shiming Zhang, John Sienkiewicz, et al.
Pageof 1